113 related articles for article (PubMed ID: 32003961)
1. A Canstatin-Derived Peptide Provides Insight into the Role of Capillary Morphogenesis Gene 2 in Angiogenic Regulation and Matrix Uptake.
Finnell JG; Tsang TM; Cryan L; Garrard S; Lee SL; Ackroyd PC; Rogers MS; Christensen KA
ACS Chem Biol; 2020 Feb; 15(2):587-596. PubMed ID: 32003961
[TBL] [Abstract][Full Text] [Related]
2. Binding stoichiometry and kinetics of the interaction of a human anthrax toxin receptor, CMG2, with protective antigen.
Wigelsworth DJ; Krantz BA; Christensen KA; Lacy DB; Juris SJ; Collier RJ
J Biol Chem; 2004 May; 279(22):23349-56. PubMed ID: 15044490
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic potential of capillary morphogenesis gene 2 extracellular vWA domain in tumour‑related angiogenesis.
Ye L; Sun PH; Sanders AJ; Martin TA; Lane J; Mason MD; Jiang WG
Int J Oncol; 2014 Oct; 45(4):1565-73. PubMed ID: 24993339
[TBL] [Abstract][Full Text] [Related]
4. Crystal structure of the von Willebrand factor A domain of human capillary morphogenesis protein 2: an anthrax toxin receptor.
Lacy DB; Wigelsworth DJ; Scobie HM; Young JA; Collier RJ
Proc Natl Acad Sci U S A; 2004 Apr; 101(17):6367-72. PubMed ID: 15079089
[TBL] [Abstract][Full Text] [Related]
5. Capillary morphogenesis gene 2 (CMG2) mediates growth factor-induced angiogenesis by regulating endothelial cell chemotaxis.
Cryan LM; Tsang TM; Stiles J; Bazinet L; Lee SL; Garrard S; Madrian E; Roberts C; Payne J; Jensen A; Frankel AE; Ackroyd PC; Christensen KA; Rogers MS
Angiogenesis; 2022 Aug; 25(3):397-410. PubMed ID: 35212873
[TBL] [Abstract][Full Text] [Related]
6. Stability of domain 4 of the anthrax toxin protective antigen and the effect of the VWA domain of CMG2 on stability.
Mamillapalli S; Miyagi M; Bann JG
Protein Sci; 2017 Feb; 26(2):355-364. PubMed ID: 27874231
[TBL] [Abstract][Full Text] [Related]
7. Human capillary morphogenesis protein 2 functions as an anthrax toxin receptor.
Scobie HM; Rainey GJ; Bradley KA; Young JA
Proc Natl Acad Sci U S A; 2003 Apr; 100(9):5170-4. PubMed ID: 12700348
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the interaction between anthrax toxin and its cellular receptors.
Liu S; Leung HJ; Leppla SH
Cell Microbiol; 2007 Apr; 9(4):977-87. PubMed ID: 17381430
[TBL] [Abstract][Full Text] [Related]
9. Anthrax Toxin Protective Antigen Variants That Selectively Utilize either the CMG2 or TEM8 Receptors for Cellular Uptake and Tumor Targeting.
Chen KH; Liu S; Leysath CE; Miller-Randolph S; Zhang Y; Fattah R; Bugge TH; Leppla SH
J Biol Chem; 2016 Oct; 291(42):22021-22029. PubMed ID: 27555325
[TBL] [Abstract][Full Text] [Related]
10. The receptors that mediate the direct lethality of anthrax toxin.
Liu S; Zhang Y; Hoover B; Leppla SH
Toxins (Basel); 2012 Dec; 5(1):1-8. PubMed ID: 23271637
[TBL] [Abstract][Full Text] [Related]
11. Heterodimeric integrin complexes containing beta1-integrin promote internalization and lethality of anthrax toxin.
Martchenko M; Jeong SY; Cohen SN
Proc Natl Acad Sci U S A; 2010 Aug; 107(35):15583-8. PubMed ID: 20713715
[TBL] [Abstract][Full Text] [Related]
12. Anthrax toxin receptor 2 is expressed in murine and tumor vasculature and functions in endothelial proliferation and morphogenesis.
Reeves CV; Dufraine J; Young JA; Kitajewski J
Oncogene; 2010 Feb; 29(6):789-801. PubMed ID: 19901963
[TBL] [Abstract][Full Text] [Related]
13. Receptor-enhanced immunogenicity of anthrax protective antigen is primarily mediated by capillary morphogenesis Protein-2.
Verma A; Moayeri M; Mocca CP; O'Mard D; Ma Q; Leppla SH; Burns DL
Vaccine; 2022 Jul; 40(32):4318-4321. PubMed ID: 35710508
[TBL] [Abstract][Full Text] [Related]
14. A FRET-based high throughput screening assay to identify inhibitors of anthrax protective antigen binding to capillary morphogenesis gene 2 protein.
Rogers MS; Cryan LM; Habeshian KA; Bazinet L; Caldwell TP; Ackroyd PC; Christensen KA
PLoS One; 2012; 7(6):e39911. PubMed ID: 22768167
[TBL] [Abstract][Full Text] [Related]
15. Long-range stabilization of anthrax protective antigen upon binding to CMG2.
Mullangi V; Mamillapalli S; Anderson DJ; Bann JG; Miyagi M
Biochemistry; 2014 Sep; 53(38):6084-91. PubMed ID: 25186975
[TBL] [Abstract][Full Text] [Related]
16. Capillary morphogenesis protein-2 is the major receptor mediating lethality of anthrax toxin in vivo.
Liu S; Crown D; Miller-Randolph S; Moayeri M; Wang H; Hu H; Morley T; Leppla SH
Proc Natl Acad Sci U S A; 2009 Jul; 106(30):12424-9. PubMed ID: 19617532
[TBL] [Abstract][Full Text] [Related]
17. The CMG2 ELISA for evaluating inhibitors of the binding of anthrax toxin protective antigen to its receptor.
Dawson RM
J Pharmacol Toxicol Methods; 2009; 59(1):50-5. PubMed ID: 19049885
[TBL] [Abstract][Full Text] [Related]
18. Recombinant canstatin inhibits angiopoietin-1-induced angiogenesis and lymphangiogenesis.
Hwang-Bo J; Yoo KH; Park JH; Jeong HS; Chung IS
Int J Cancer; 2012 Jul; 131(2):298-309. PubMed ID: 21823121
[TBL] [Abstract][Full Text] [Related]
19. Human alpha1 type IV collagen NC1 domain exhibits distinct antiangiogenic activity mediated by alpha1beta1 integrin.
Sudhakar A; Nyberg P; Keshamouni VG; Mannam AP; Li J; Sugimoto H; Cosgrove D; Kalluri R
J Clin Invest; 2005 Oct; 115(10):2801-10. PubMed ID: 16151532
[TBL] [Abstract][Full Text] [Related]
20. New insights into short peptides derived from the collagen NC1 α1, α2, and α3 (IV) domains: An experimental and MD simulations study.
Chamani R; Taleqani MH; Imanpour A; Khatami M
Biochim Biophys Acta Proteins Proteom; 2022 Apr; 1870(4):140769. PubMed ID: 35151893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
